Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension

American Journal of Hypertension

Volumn 11, Issue 2, 1998, Pages 174-183

  Mondorf, Ulrich F ^a   Russ, Andreas ^a   Wiesemann, Annette ^a   Herrero, Martina ^a   Oremek, Gerhard ^a   Lenz, Tomas ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Blood pressure; Gene polymorphism; Genetics

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; CAPTOPRIL; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0031907082     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00402-0     Document Type: Article

References (51)

1. Ruiz-Ortega M, Gomez-Garre D, Alcazar R, et al: Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. J Hypertens 1994;12(suppl):S51-S58.
2. Klahr S, Ishidoya S, Morrissey J: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 1995;26:141-146.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.
4. Castellano M, Muiesan ML, Rizzoni D, et al: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation 1995;91:2721-2724.
5. O'Dell SD, Humphries SE, Day IN: Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 1995;73:368-371.
6. Morgan K, Wharton J, Webb JC, et al: Co-expression of renin-angiotensin system component genes in human atrial tissue. J Hypertens 1994;12(suppl):S11-S19.
7. Kim HS, Krege JH, Kluckman KD, et al: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995;92:2735-2739.
8. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH: The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995;95:948-953.
9. Harden PN, Geddes C, Rowe PA, et al: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995;345: 1540-1542.
10. Katsuya T, Koike G, Yee TW, et al: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345:1600-1603.
11. Ludwig E, Corneli PS, Anderson JL, et al: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995;91:2120-2124.
12. Iwai N, Shimoike H, Ohmichi N, et al: Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995;25:688-693.
13. Ishigami T, Umemura S, Iwamoto T, et al: Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995;91:951-954.
14. Kamitani A, Rakugi H, Higaki J, et al: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995;25:950-953.
15. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H: Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese (letter). Lancet 1995;346:515.
16. Rotimi C, Morrison L, Cooper R, et al: Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994;24:591-594.
17. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
18. Zee RYL, Lou Y, Morris B, Morris G: Association of a polymorphism of the angiotensin I converting enzyme with essential hypertension. Biochem Biophys Res Commun 1992;181:486-492.
19. Duru K, Farrow S, Wang JM, et al: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994;7:759-762.
20. Ishigami T, Iwamoto T, Tamura K, et al: Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. Am J Hypertens 1995;8:95-97.
21. Schmidt S, van Hooft IM, Grobbee DE, et al: Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993; 11:345-348.
22. Harrap SB, Davidson HR, Connor JM, et al: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993;21:455-460.
23. Jeunemaitre X, Lifton RP, Hunt SC, et al: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992;1:72-75.
24. Nakai K, Itoh C, Miura Y, et al: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202.
25. Ruiz J, Blanche H, Cohen N, et al: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-3665.
26. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction [see comments]. Nature 1992;359:641-644.
27. Kaski JC: Are polymorphisms in the ACE gene a potent genetic risk factor for restenosis? Br Heart J 1994;72:101.
28. Raynolds MV, Bristow MR, Bush EW, et al: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy [see comments]. Lancet 1993;342:1073-1075.
29. Iwai N, Ohmichi N, Nakamura Y, et al: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90: 2622-2628.
30. Schunkert H, Hense HW, Holmer SR, et al: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy [see comments]. N Engl J Med 1994;330: 1634-1638.
31. Lindpaintner K: Genes, hypertension, and cardiac hypertrophy [editorial; comment]. N Engl J Med 1994;330: 1678-1679.
32. Hamon M, Bauters C, Amant C, et al: Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995;92:296-299.
33. Lindpaintner K, Pfeffer MA, Kreutz R, et al: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
34. Müller FB, Sealey JE, Case DB, et al: The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986;80:633-644.
35. Neels HM, Van Sande ME, Scharpe SL: Sensitive colorimetric assay for ACE in serum. Clin Chem 1983;29: 1399-1403.
36. Russ AP, Maerz W, Ruzicka V, et al: Rapid detection of the hypertension-associated Met235-Thr allele of the human angiotensinogen gene. Hum Molec Genet 1993; 2:609-610.
37. Lachurie ML, Azizi M, Guyene TT, et al: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995;91:2933-2942.
38. Cambien F, Costerousse O, Tiret L, et al: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-676.
39. McKenzie CA, Julier C, Forrester T, et al: Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 1995;57:1426-1435.
40. Tiret L, Rigat B, Viskivis S: Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
41. Allan DR, McKnight JA, Kifor I, et al: Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 1994;24:516-522.
42. Ueda S, Elliott HL, Morton JJ, Connell JM: Enhanced presser response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995;25:1266-1269.
43. Todd GP, Chadwik IG, Higgins KS, et al: Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects. Br J Clin Pharmacol 1995;39: 131-134.
44. Dudley C, Keavney B, Casadei B, et al: Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of the renin-angiotensin system genes. J Hypertens 1996;14:259-262.
45. Yoshida H, Kuriyama S, Atsumi Y, et al: Angiotensin I converting enzyme polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996;50:657-664.
46. Smithies O, Kim HS: Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA 1994;91:3612-3615.
47. Harrap SB: Public health, cardiovascular disease and molecular biology. Kidney Int 1994;46:1546-1549.
48. Hingorani AD, Jia H, Stevens PA, et al: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotenin converting enzyme inhibition. J Hypertens 1995;13:1602-1609.
49. Hopkins PN, Lifton PR, Hollenberg NK, et al: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996;14:199-207.
50. Caulfield M, Lavender P, Newell-Price J, et al: Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96:687-692.
51. Jeunemaitre X, Charru A, Chatellier G, et al: M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993; 11(suppl 5):S80-S81.